Larimar Therapeutics, Inc. (LS:A2P5PP) IPO

Larimar Therapeutics, Inc.

IPO

Went public as ZAFGEN, INC. Priced at US$16.00 a share on Jun 18, 2014.

Price
US$16.00 a share
Shares offered
6,000,000 shares of common stock
Offering size
US$96 million
Underwriters' option
Up to 900,000 more shares
Underwriters
Leerink Partners, Cowen and Company, Canaccord Genuity, JMP Securities · In the order on the cover
Shares delivered
On or about Jun 24, 2014

Steps

StepWhen
Draft sent to the SEC in confidenceJan 31, 2014
Filed publiclyApr 18, 2014
Amended 5 timesNewest Jun 16, 2014
Shares registered with an exchangeJun 18, 2014
Declared effective by the SECJun 18, 2014
Final prospectus, with the priceJun 19, 2014

From the cover of the final prospectus (424B4) filed Jun 19, 2014